Inhibition of carboplatin-induced DNA interstrand crosslink repair by gemcitabine in patients receiving these drugs for ‘platinum-resistant’ ovarian cancer

. Author manuscript; available in PMC: 2015 Jan 5.

Published in final edited form as: Clin Cancer Res. 2010 Aug 18;16(19):4899–4905. doi: 10.1158/1078-0432.CCR-10-0832

Figure 4. Percentage repair of carboplatin-induced DNA interstrand crosslinks in patient PBLs at 48 hours in the blood samples taken after treatment with carboplatin alone and after treatment with the combination of carboplatin and gemcitabine.